Kindbody Company Profile

Background

Founded in late 2018, Kindbody is a technology-driven fertility clinic network and family-building benefits provider for employers. The company aims to make fertility and family-building care more accessible and affordable by offering comprehensive virtual and in-person services. As the only family-building benefits provider that owns and operates fertility clinics, Kindbody delivers a seamless continuum of care, enhancing patient experience and health outcomes.

Key Strategic Focus

Kindbody's strategic focus centers on providing integrated fertility and family-building services through a combination of proprietary technology and a nationwide network of clinics. By contracting directly with employers, the company offers comprehensive care to employees, resulting in cost savings of 25%-30% for employers. This direct care model allows Kindbody to decrease costs, improve patient experience, and deliver superior health outcomes.

Financials and Funding

As of March 2023, Kindbody has raised over $290 million in equity and debt funding, with a valuation of $1.8 billion. The most recent funding round, led by Perceptive Advisors, secured $100 million to support future growth, including the expansion of clinics in underserved U.S. markets and investments in operations to enhance the care model.

Pipeline Development

In 2022, Kindbody added 42 large employer clients, including Walmart, and became the fertility benefits provider for 112 companies, covering more than 2.4 million lives. The company made strategic acquisitions to accommodate growth, including Vios Fertility Institute, a genomics company, and a gestational surrogacy agency, further expanding its continuum of care. As of March 2023, Kindbody owns and operates 31 clinics nationwide, with plans to open ten new clinics in underserved markets.

Technological Platform and Innovation

Kindbody's proprietary technology platform includes a HIPAA-compliant electronic medical record system (KindEMR) that supports the full spectrum of reproductive health and family-building care. The KindEMR integrates virtual and in-person care, offering online scheduling, an intuitive patient portal, and real-time access to assessments and test results. This technology enables personalized care plans and supports various paths to parenthood, including fertility preservation, genetic testing, IVF, donor and surrogacy services, and adoption.

Leadership Team

Gina Bruzzichesi: Co-CEO and President. Previously served as Chief Operating Officer at Aspen Dental Management and held senior operational roles at CLEAR, WeWork, and Avis.

Scott Bruckner: Co-CEO and Chief Financial Officer. Former CFO at Fluid Truck and Casa Systems, with extensive experience in M&A and public and private equity and debt financings.

Shilpa Patel: Co-CEO and Chief Business & Legal Officer. Previously worked at Quartet Health and Oscar Insurance Corporation, with a background in healthcare law.

Dr. Fahimeh Sasan: Founding Physician & Chief Innovation Officer. Board-certified Ob/Gyn and Assistant Professor at Mount Sinai Hospital in New York, dedicated to delivering comprehensive care with a focus on risk reduction and personalized experience.

Dr. Lynn Westphal: Lead Chief Medical Officer, Medicine + Research & REI. Former Professor at Stanford University, with expertise in fertility preservation and reproductive endocrinology.

Dr. Kristin Bendikson: Chief Medical Officer, Clinical Development & REI. Completed residency at Harvard and fellowship at Cornell, with a focus on improving IVF success and outcomes.

Dr. Roohi Jeelani: Chief Medical Officer, Growth and Business Development & REI. Double board-certified Reproductive Endocrinologist and Infertility Specialist, with a special interest in oncofertility and oocyte cryopreservation.

Leadership Changes

In March 2024, Kindbody expanded its executive team with the appointment of six executives to support the next stage of growth:

Gina Bruzzichesi: Appointed as Chief Operating Officer, the company's first in its five-year history.

Scott Bruckner: Appointed as Chief Financial Officer.

Haleigh Tebben: Joined as Chief Revenue Officer, bringing 25 years of experience in employer benefits, consulting, and healthcare.

Tim Springer: Appointed as Chief Compliance Officer, the company's first in its history.

Jason Barritt, PhD: Appointed as Chief Scientific Officer.

Matt Slepian: Serves as Chief Accounting Officer, the company's first in its history.

Competitor Profile

Market Insights and Dynamics

The fertility and family-building market is experiencing significant growth, driven by increasing demand for fertility services among millennials and the expansion of employer-sponsored fertility benefits. The IVF market alone is projected to reach $22 billion by 2024, growing at 10% annually.

Competitor Analysis

Traditional Fertility Clinics: Standalone clinics and hospital-affiliated reproductive medicine departments dominate the market, typically charging higher prices for services.

Tech-Enabled Fertility Providers: Companies like Extend Fertility focus on egg freezing at lower price points, while Tia provides comprehensive women's health services without offering fertility treatments.

Employer Benefits Platforms: Progyny partners with self-insured employers to provide fertility coverage through a network of clinics, and Maven Clinic offers virtual care coordination and fertility benefits through employers.

Strategic Collaborations and Partnerships

Kindbody has established partnerships with 132 leading employers, covering almost 2.7 million lives. The company has also made strategic acquisitions, including Vios Fertility Institute, a genomics company, and a gestational surrogacy agency, to expand its continuum of care.

Operational Insights

Kindbody's vertically integrated model, combining physical clinics with a digital platform, allows for cost savings and improved patient experience. By owning and operating its clinics, the company offers services at significantly lower costs than traditional clinics, positioning itself to capture market share as fertility treatments become more mainstream.

Strategic Opportunities and Future Directions

Kindbody plans to continue its nationwide expansion by opening additional clinics in underserved markets and investing in operations to enhance its care model. The company aims to achieve EBITDA positive and cash flow positive status in the near future, positioning itself for potential public offering when market conditions are favorable.